Optimizing management of distal ulcerative colitis.

about

Ulcerative proctitis: a review of pharmacotherapy and management.Recent advances in the management of distal ulcerative colitis.

P2860

Q37111844-1B8DEDB3-BC09-436A-A41A-EA17456B6E52 Q42730491-2EE20C22-0B6B-47A7-B4FE-826C64EAF72E

P2860

Optimizing management of distal ulcerative colitis.

Item

http://www.wikidata.org/entity/Q36459902

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Optimizing management of distal ulcerative colitis.

@ast

Optimizing management of distal ulcerative colitis.

@en

type

Item

label

Optimizing management of distal ulcerative colitis.

@ast

Optimizing management of distal ulcerative colitis.

@en

prefLabel

Optimizing management of distal ulcerative colitis.

@ast

Optimizing management of distal ulcerative colitis.

@en

P1476

Optimizing management of distal ulcerative colitis.

@en

P2093

Nilsson A

http://www.w3.org/2001/XMLSchema#string

P2860

Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD)

Inflammatory Bowel Disease

Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis

Infliximab for induction and maintenance therapy for ulcerative colitis

Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs

Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis.

Epidemiology and the natural course of inflammatory bowel disease.

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial.

An analysis of an inflammatory bowel disease practice in an urban community hospital.

Optimum dose of olsalazine for maintaining remission in ulcerative colitis.

P304

511-523

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1080/00365520600575738

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16638692

http://www.w3.org/2001/XMLSchema#string

Optimizing management of distal ulcerative colitis.

about

P2860

P2860

Optimizing management of distal ulcerative colitis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698